Product Description: Price
In tissues with high energy requirement, such as heart, up to 50 – 70% of energy comes from fatty acid beta-oxidation, which converts multiple types of fatty acids to acetyl-CoA with concomitant production of FADH2 and NADH in the mitochondria. This strictly aerobic oxidative pathway consists of four distinct steps: acyl-CoA dehydrogenation by acyl-CoA dehydrogenase, hydration by enoyl-CoA hydratase, dehydrogenation by 3-hydroxyacyl-CoA dehydrogenase, and thiolytic cleavage by a thiolase. The importance of the beta-oxidation system is exemplified by the existence of a group of genetic diseases categorized as fatty acid oxidation disorders (FAODs), which are a heterogeneous group of defects in fatty acid transport and oxidation. Measurement of FAO activity thus provides valuable insights into the pathophysiologic and metabolic basis of many diseases. The non-radioactive FAO assay is based on oxidation of palmitoyl-CoA (long chain), octanoyl-CoA (medium chain), or butyryl-CoA (short chain). Generation of NADH is coupled to the reduction of the tetrazolium salt INT to formazan. The intensity of the red-colored formazan is proportional to increased FAO activity. Please select E-141L (palmitoyl-CoA), E-141M (octanoyl-CoA), or E-141S (butyryl-CoA) for your order. E-141L, E-141M, and E-141S are used to assess the cell/tissue capacity for oxidation of long chain, medium chain, and short chain fatty acids, respectively.
#FattyAcidOxidation #FAO #beta-oxidation #fattyacid #acetyl-CoA #FAOD #palmiticacid #octanoicacid #butyricacid
E-141L Kit Components:
FAO Assay Solution: 5 ml, store at -80°C (for 100 wells)
10x FAO Substrate (L): 0.5 ml, store at -80ºC
10x Sample Buffer: 25 ml, store at 4ºC
E-141M Kit Components:
FAO Assay Solution: 5 ml, store at -80°C (for 100 wells)
20x FAO Substrate (M): 0.25 ml, store at -80ºC
10x Sample Buffer: 25 ml, store at 4ºC
E-141S Kit Components:
FAO Assay Solution: 5 ml, store at -80°C (for 100 wells)
25x FAO Substrate (S): 0.2 ml, store at -80ºC
10x Sample Buffer: 25 ml, store at 4ºC
SDS:
DMSO, INT, Tris
Related Kits:
HK Assay, L-Lactate Assay, ATP Assay
Citation:
Kwong et al
Metabolic role of fatty acid binding protein 7 in mediating triple-negative breast cancer cell death via PPAR-alpha signaling
J. Lipid Res. 60:1807, 2019
Cheng et al
Targeting DGAT1 ameliorates glioblastoma by increasing fat catabolism and oxidative stress
Cell Metabolism 32, 229-242, 2020
Chen et al
HNF4 regulates fatty acid oxidation and is required for renewal of intestinal stem cells in mice
Gastroenterology 158(4):985-999, 2020
Veeriah et al
Long-term oral administration of an HNF4α agonist prevents weight gain and hepatic steatosis by promoting increased mitochondrial mass and function
Cell Death & Disease 13(1):89, 2022
Xu et al
Hepatic PRMT1 ameliorates diet-induced hepatic steatosis via induction of PGC1α
Theranostics 12(6):2502-2518, 2022
Huang et al
PERM1 regulates genes involved in fatty acid metabolism in the heart by interacting with PPARα and PGC‑1α
Scientific Reports 12:14576, 2022